Chris Garcia
Family Medicine · Texas City, TXNPI 1588625560
Payments from drug & device makers
Across 46 payments — averaging $51.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$1K
- Gilead$364
- E.r. Squibb & Sons, L.L.C.$155
- Dexcom, Inc.$125
- Daiichi Sankyo Inc.$125
- Bayer$125
- plus $493 from 18 others
What the payments were for
- Travel & lodging$1,00142%
- Food & beverage$1,38858%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 3 | $1,001 |
| Gilead | 14 | $364 |
| E.r. Squibb & Sons, L.L.C. | 3 | $155 |
| Dexcom, Inc. | 1 | $125 |
| Daiichi Sankyo Inc. | 1 | $125 |
| Bayer | 1 | $125 |
| Bioventus LLC | 1 | $80 |
| Alcon | 2 | $46 |
| Merck | 2 | $46 |
| Procept Biorobotics Corporation | 1 | $41 |
| AbbVie | 2 | $37 |
| Abbott | 2 | $35 |
| Tolmar Pharmaceuticals, Inc. | 2 | $30 |
| Antares Pharma, Inc. | 1 | $21 |
| Organon | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
| Novo Nordisk | 1 | $15 |
| AstraZeneca | 1 | $14 |
| GSK | 1 | $13 |
| Shire North American Group Inc | 1 | $13 |
| Acerus Pharmaceuticals Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$982
- Kerendia$125
- DEXCOM G7 GSS (161)$125
- Enhertu$125
- CAMZYOS$121
How this compares
$2,389 in reported general payments places this provider in the 75th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 35 | $50,788 |
| JardianceEmpagliflozin | 19 | $17,257 |
| Duloxetine Hcl | 33 | $1,785 |
| Gabapentin | 70 | $1,636 |
| Atorvastatin Calcium | 119 | $1,115 |
| Pantoprazole Sodium | 58 | $594 |
| Hydroxyzine Hcl | 14 | $579 |
| Rosuvastatin Calcium | 22 | $409 |
| Amlodipine Besylate | 69 | $407 |
| Glimepiride | 27 | $386 |
| Lisinopril | 44 | $385 |
| Baclofen | 16 | $350 |
| Losartan Potassium | 24 | $305 |
| Metformin Hcl | 61 | $294 |
| Tamsulosin Hcl | 25 | $290 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia | $46 | $50,78835 claims |
| Boehringer IngelheimJardiance | $17 | $17,25719 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Texas City
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
- Bonnie ColvilleHouston$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.